American College of Cardiology/American Heart Association clinical practice guidelines: Part I. Where do they come from?

Circulation

Volumn 107, Issue 23, 2003, Pages 2979-2986

  Gibbons, Raymond J ^a   Smith, Sidney ^b   Antman, Elliott ^c  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIANGINA PECTORIS AGENT; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPYRIDAMOLE; GLYCERYL TRINITRATE; NITRATE; VASOCONSTRICTOR AGENT; VASODILATOR AGENT;

ALGORITHM; ARTICLE; CARDIOLOGY; CLINICAL PRACTICE; HEART INFARCTION; HUMAN; MEDICAL SOCIETY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK FACTOR; STABLE ANGINA PECTORIS;

ADVISORY COMMITTEES; AGED; ANGINA PECTORIS; CONFLICT OF INTEREST; CONSENSUS; DISEASE MANAGEMENT; EVIDENCE-BASED MEDICINE; HUMANS; HYPERTENSION; MALE; MYOCARDIAL INFARCTION; PRACTICE GUIDELINES; RANDOMIZED CONTROLLED TRIALS; RISK REDUCTION BEHAVIOR; UNITED STATES;

EID: 0038170272     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000063682.20730.A5     Document Type: Article

References (13)

1. Gibbons RJ, Chatterjee K, Daley J, et al. ACC/AHA/ACP guidelines for the management of chronic stable angina: a report of the American College of Cardiology/American Heart Association/American College of Physicians Task Force on Practice Guidelines (Committee on the Management of Patients with Chronic Stable Angina). J Am Coll Cardiol. 1999;33:2093-2197.
2. Frye RL, Collins JJ, DeSanctis RW, et al. Guidelines for permanent cardiac pacemaker implantation, May 1984: a report on the Joint American College of Cardiology/American Heart Association Task Force on Assessment of Cardiovascular Procedures (Subcommittee on Pacemaker Implantation). Circulation. 1984;70:331-339.
3. Greenspan AM, Kay HR, Bergor BC, et al. Incidence of unwarranted implantation of permanent cardiac pacemakers in a large medical population. N Engl J Med. 1988;318:158-163.
4. McCormick D, Gurwitz JH, Lessard D, et al. Use of aspirin, betablockers, and lipid-lowering medications before recurrent acute myocardial infarction: missed opportunities for prevention? Arch Intern Med. 1999;159:561-567.
5. Wennberg JE, Birkmeyer JD, Birkmeyer NJO, et al. The Dartmouth Atlas of Cardiovascular Health Care. Chicago. III: AHA Press; 1999.
6. American College of Cardiology. Manual for ACC/AHA Guideline Writing Committees. Available at: http: //www.acc.org/clinical/manual/ manual_introltr.htm and http:/circ.ahajournals.org/manual/. Accessed January 27, 2003.
7. Choudry NK, Stelfox HT, Detsky AS. Relationships between authors of clinical practice guidelines and the pharmaceutical industry. JAMA. 2002;287:612-617.
8. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20 536 high-risk individuals: a randomised placebo-controlled trial. Lancet. 2002;360:23-33.
9. Berthold HK, Sudhop T, von Bergmann K. Effect of a garlic oil preparation on serum lipoproteins and cholesterol metabolism: a randomized controlled trial. JAMA. 1998;279:1900-1902.
10. Isaacsohn JL, Moser M, Stein EA. et al. Garlic powder and plasma lipids and lipoproteins: a multicenter, randomized, placebo-controlled trial. Arch Intern Med. 1998;158:1189-1194.
11. Jain AK, Vargas R, Gotzkowsky S, et al. Can garlic reduce levels of serum lipids? A controlled clinical study. Am J Med. 1993;94:632-635.
12. Warshafsky S, Kamer RS, Sivak SL. Effect of garlic on total serum cholesterol: a meta-analysis. Ann Intern Med. 1993;119:599-605.
13. Silagy CA, Neil HA. A meta-analysis of on the effect of garlic on blood pressure. J Hypertens. 1994;12:463-468.